-
Press Release
2023/12/06
Abnova’s Nanobody Initiative for the New Era of Research and Therapy
-
Press Release
2023/09/18
Abnova Introduces Advanced miRNA Probe Customization Services and Catalog Products, Revitalizing the Field of miRNA Research
-
Conference
2023/09/05
Abnova Excited to Join NIH Research Festival 2023 for Collaborative Biotechnology Showcase
-
Press Release
2023/07/31
Abnova Launches circRNA Sponge Catalog Products and Customized Services, Advancing circRNA Sponge-miRNA Interaction Analysis Research
-
Press Release
2023/04/12
Abnova Launches Innovative Oligo(dT) IVT mRNA Purification Instrument, Spiraltor™ 48
-
Press Release
2021/07/13
Abnova Outpace Competition by Speeding Up COVID-19 Neutralizing Antibody Tests for the Post COVID-19 Era
-
Press Release
2021/06/17
Abnova COVID-19 Antigen Rapid Test Nasal Cavity Sampling Advantage Speeds Up Home Use IRB Submission and Clinical Study
-
Press Release
2021/03/23
Abnova File for Universal COVID-19 Self-Amplifying mRNA Vaccine Patent and Establish GMP Manufacturing Partnership
-
Press Release
2021/03/12
Abnova COVID-19 Humanized Antibody Effective Against Both UK (B.1.1.7) and South Africa (B.1.351) Variants
-
Press Release
2021/02/23
Abnova Introduces Neutralizing Antibody Test for COVID-19, UK, and South Africa Variants for Post-Vaccine Era
